By Dr. Vishal Saini, M.D., FAASM — Mid-West Center for Sleep Disorders
Let me start by saying something I mean sincerely: if your sleep medication has been delayed, stuck, or denied, your frustration is completely valid. Being told that a prescription your physician wrote — for a real, diagnosed condition — now needs to clear another approval process before your pharmacy will fill it is maddening. You did everything right. You came in, you got evaluated, you got a plan. And then the plan hit a wall.
I want to be honest about where that wall comes from, because it's the single most misunderstood part of modern medicine — and because, understandably, the frustration often lands on the clinic standing in front of you rather than on the system standing behind the curtain. This article is my attempt to pull back that curtain: to explain what prior authorization is, why sleep medications for insomnia and hypersomnia are among the hardest hit, why your care team genuinely cannot just "fix it," and — most importantly — what you can do to move things forward and feel less powerless.
What Prior Authorization Actually Is
Prior authorization (often shortened to "prior auth" or "PA") is a requirement imposed by your health insurance plan — and administered by its pharmacy benefit manager (PBM), the middle company that runs the drug side of your benefits — that a medication be approved before they will pay for it. Your physician's prescription is no longer enough on its own. The insurer wants paperwork, justification, and often proof that you've already tried and failed other (usually cheaper) options first.
It is worth being fair about the stated rationale: insurers use prior authorization as a cost-control and safety tool, to steer prescribing toward lower-cost drugs and to flag potential misuse. In a small number of situations that logic is defensible. The problem is scale. Prior authorization has expanded far beyond genuinely high-risk or high-cost edge cases and now routinely lands on ordinary, appropriate, physician-directed treatment — turning a clinical decision into an administrative negotiation.
The consequences are not hypothetical. In the American Medical Association's national physician surveys on prior authorization, the findings are strikingly consistent year after year: about nine in ten physicians report that prior authorization delays patients' access to necessary care, nearly four in five say it can lead patients to abandon a recommended treatment altogether, and roughly one in four report that prior authorization has led to a serious adverse event for a patient in their care. Physicians and their staff spend, on average, well over a dozen hours every week — often the equivalent of a full extra workday — just processing these requests. This is a system-wide burden, documented across all of medicine, not a quirk of any one clinic.
"A prescription used to be a clinical decision between a patient and a physician. Prior authorization quietly turned it into a negotiation with a third party who has never met you — and who profits from saying 'not yet.'" — Dr. Vishal Saini
Why Sleep Prescriptions Get Hit Especially Hard
Sleep medicine is unusually exposed to prior authorization, for reasons specific to our field.
Insomnia: the "fail first" trap
Many of the most effective modern insomnia medications — the dual orexin receptor antagonists such as suvorexant, lemborexant, and daridorexant, which promote sleep while largely sparing your natural sleep architecture — are brand-name drugs. Insurers frequently bury them behind step therapy (also called "fail first"): a rule that you must first try, and fail, one or more older, cheaper medications — often a generic like zolpidem or trazodone — before they will approve the drug your physician actually chose for you.
Think about what that means in practice. Your doctor may have selected a specific medication precisely because it fits your situation — your other conditions, your other prescriptions, your history. Step therapy overrides that judgment and forces a detour through drugs your physician may have deliberately avoided, purely to satisfy a formulary tier. You are, in effect, required to be treated sub-optimally on paper before you're allowed the treatment that was right in the first place.
Hypersomnia and narcolepsy: expensive, controlled, and heavily gated
For the central disorders of hypersomnolence — narcolepsy, idiopathic hypersomnia — the barriers are even higher. The wake-promoting and consolidating medications these conditions require (agents such as modafinil and armodafinil, solriamfetol, pitolisant, and the oxybates) are expensive, tightly regulated, and almost always subject to prior authorization, specialty-pharmacy routing, and in several cases federally mandated safety programs (REMS) that add their own enrollment steps. A single one of these prescriptions can involve the clinic, the specialty pharmacy, the PBM, and a separate REMS portal — each a potential point of delay.
Idiopathic hypersomnia deserves special mention, because it exposes the cruelty of the system most clearly. For years there was no FDA-approved medication for it at all, which meant every effective treatment was technically "off-label" — and insurers love to deny off-label prescriptions, even when they represent the genuine standard of care that sleep specialists have used for decades. Patients with a debilitating, well-documented disorder can find themselves denied simply because the paperwork category doesn't exist in the payer's system.
How This Delays Your Care — Step by Painful Step
From the outside, a delay can look like the clinic dropped the ball. From the inside, here is what is usually happening:
- Day 0: Your physician prescribes the right medication and sends it to the pharmacy.
- The pharmacy rejects the claim: not because anything is wrong, but because the plan flags it as "requires prior authorization." You may hear about this before we do.
- The clinic submits the prior authorization: our staff completes the payer's form, attaches records, and documents your diagnosis and rationale — unpaid administrative work done on your behalf.
- We wait on the insurer. This is the part no one controls but them. It can take days. For some drugs, weeks.
- The insurer often denies it anyway — citing step therapy, a formulary preference, or missing "documentation" — and we begin the appeal: a letter of medical necessity, sometimes a peer-to-peer review in which your physician must get on the phone to argue your case to a reviewer who may not even be a sleep specialist.
- Only then, sometimes, approval — or a forced switch to a different drug (non-medical switching), which restarts the clinical clock and can mean weeks of a medication that wasn't the first choice.
Every one of those steps adds days. Stack a denial and an appeal on top of a specialty-pharmacy hand-off, and a prescription written on a Monday can take the better part of a month to reach you. During that month, your insomnia or your daytime sleepiness doesn't pause. That is the real harm: not paperwork for its own sake, but treatable suffering, extended by an administrative process.
Why Your Clinic Can't Simply "Fix" It
Here is the part I most want patients to understand, said plainly and without defensiveness.
The clinic does not control your insurance benefits, your formulary, your plan's step-therapy rules, or the approval decision. Those belong to your insurer and its PBM. We can request, document, justify, appeal, and advocate — and we do all of that, routinely, at no charge to you, on time we are not reimbursed for. What we cannot do is overrule the payer. If your plan says a drug requires you to fail two others first, no amount of effort on our end erases that rule; only the insurer can waive it, and only you (or your employer, who buys the plan) are their customer.
It's a bit like being angry at the airline gate agent for a weather delay. The person in front of you is the face of the system, so the frustration lands there — but the gate agent didn't cause the storm, and can't clear the skies. Your sleep team is the gate agent here. We are, genuinely, on your side of the counter, working the phones with the same airline that's holding us all up.
"We feel the delay too. Every hour my staff spends re-faxing a form or sitting on hold for a peer-to-peer is an hour we'd rather spend on your care. When a prior auth stalls, the clinic and the patient are on the same team — the obstacle is somewhere else entirely." — Dr. Vishal Saini
I'll say one more thing directly, because it matters. A few patients, in their frustration, have expressed anger at the clinic over insurance delays. I understand the impulse completely — you're hurting and you want someone accountable. But that anger lands on the people who were fighting for you, while the insurer and PBM who actually delayed your care remain invisible and untouched. If you take nothing else from this article, take this: your energy is far better aimed at the entity that made the rule than at the team trying to get you around it.
What You Can Do — Concrete Ways to Take Back Some Power
You are not helpless in this process. In fact, as the plan's actual customer, you often have leverage we don't. Here is how to use it.
1. Learn your own coverage before you're blindsided. Call the member-services number on your insurance card and ask two specific questions: "Does this medication require prior authorization or step therapy?" and "Can you send me the formulary and the exact criteria for approval?" Knowing the rules in advance lets us build the strongest possible request the first time.
2. Make sure your history is documented — it's your best weapon against step therapy. If you've already tried and not tolerated the cheaper drugs the insurer wants you to "fail," tell us, in detail, with names and dates. Documented prior failures are often the fastest route to an exception. If it's in your record, we can use it.
3. Exercise your right to appeal — and escalate it. A denial is not the end. You have a legal right to an internal appeal, and if that fails, an independent external review by a party not employed by your insurer. Ask the clinic for a letter of medical necessity to support it, and don't be shy about filing. Appeals succeed more often than people expect, precisely because many initial denials are automated and thin.
4. Go over the PBM's head to the people who answer to you. If you have insurance through an employer, your company's HR or benefits manager has real power — many employer plans are self-funded, meaning the employer, not the insurer, ultimately pays, and can grant exceptions. A polite note explaining that a benefit design is delaying medically necessary care can move mountains a clinic's fax never will. You can also file a complaint with your state's insurance commissioner (or department of insurance), who regulates these practices.
5. Attack the cost problem directly. Ask us and your pharmacist about manufacturer copay cards and patient-assistance programs — many brand sleep and wake-promoting drugs have them, sometimes bringing a stuck prescription down to a few dollars while the appeal grinds on. Cash-price tools (like GoodRx) occasionally beat your insurance entirely for generics. And ask whether a 90-day supply or a manufacturer bridge program can keep you covered during a gap.
6. Stay reachable — you're part of the team. The single most common cause of a further delay is a peer-to-peer review that can't be scheduled or a specialty-pharmacy call that goes unanswered. Respond quickly when we or the pharmacy reach out, and let us know the moment a pharmacy tells you a claim was rejected — often you'll hear it before the rejection reaches us.
7. Turn frustration into advocacy. Sleep-medicine organizations, including the American Academy of Sleep Medicine, and numerous patient-advocacy groups are actively lobbying for prior-authorization reform — gold-carding programs, faster decision timelines, step-therapy limits. Your story, told to a state legislator or shared with these groups, is worth more than you think. Reform happens when patients, not just physicians, demand it.
The Bottom Line
Prior authorization is a barrier your insurer and its pharmacy benefit manager place between you and the sleep treatment your physician already decided you need. It hits insomnia and hypersomnia care especially hard — through step therapy, specialty-pharmacy routing, and denials of well-established treatments — and it delays real relief for real conditions. Your clinic can fight it, and does, but cannot overrule it, because the rules and the decision belong to the payer, not to us. The most powerful voice in this system is not your doctor's — it's yours, because you are the customer the insurer actually answers to. Learn your coverage, document your history, appeal every denial, escalate to your employer and your state regulator, and lean on assistance programs to bridge the gap. And know that when a prior authorization is holding up your care, your sleep team isn't the obstacle — we're in the trench beside you, aiming at the same wall.
Dr. Vishal Saini, M.D., FAASM is the Research & Medical Director at Mid-West Center for Sleep Disorders, serving patients with insomnia, sleep apnea, narcolepsy, and complex hypersomnia disorders in Lansing, Traverse City, and Eaton Rapids. Our team handles prior authorizations and appeals for our patients as a routine part of care.
Struggling with a delayed or denied sleep prescription? Bring it to us — we'll fight it with you.
Book a Consultation → | (517) 887-6733
Note on sources: Burden statistics are drawn from the American Medical Association's annual national survey of physicians on prior authorization, which has reported consistent figures across recent years (roughly 90%+ reporting care delays, nearly 80% reporting treatment abandonment, and about one in four reporting a serious adverse event linked to prior authorization). Patient rights to internal appeal and independent external review are established under federal and state insurance law. Advocacy for prior-authorization reform in sleep medicine is led by the American Academy of Sleep Medicine and allied patient organizations.